Plain language summary Screening for prostate cancer Prostate cancer is one of the most prevalent forms of cancer in men worldwide. Screening for prostate cancer requires diagnostic tests to be performed in the absence of any symptoms or indications of...
Other screening tests for prostate cancer The effect of digital rectal examination (DRE) as a screening test on death from prostate cancer has not been evaluated in randomized studies. Five case-control studies have not yielded consistent results, which is thought to be due to a low sensitivi...
As with all screening tests, some men without prostate cancer will receive positive PSA test results (ie, “false-positive” results). The false-positive rate for the PSA test depends on the PSA threshold used. Among 5 ERSPC sites that reported the false-positive rate, approximately 1 in 6...
Healthy individuals can discuss additional individualised screening tests for prostate cancer, liver cancer, gastric cancer and lung cancer with their doctors. Delivering personalised treatment to patients In this day and age, cancer treatment options have extended to a wide arsenal of treatme...
Objective To compare the performance of PSA testing, MRI, and ultrasonography as screening tests for prostate cancer. Design, Setting, and Participants This prospective, population-based, blinded cohort study was conducted at 7 primary care practices and 2 imaging centers in the United Kingdom. Men...
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer Prostate, 45 (2000), pp. 19-35 View in ScopusGoogle Scholar [20] T.D. Brett An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prost...
New prostate cancer screening tests In the last years, the scientific community has witnessed a significant evolution in PCa screening strategies. Firstly, active surveillance has been validated as an effective attitude in PCa patients with a low probability of progression. In these cases, treatment ...
a preventive service for men 45 years of age and older who are considered average-risk for prostate cancer, and for men 40 years of age and older who are considered at high-risk for prostate cancer. Risk groups include African-American men and men with a family history of prostate cancer;...
Dr. Ian Walker, Cancer Research UK's director of clinical research, said: "We're delighted to partner with the MRC to support such an ambitious project. Providing men with an accurate diagnosis is one of the biggest challenges inprostate cancer. Current tests are blunt and unreliable when it...
The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. Prostate cancer screening with serum prostate-specific antigen (PSA) and digital rectal examination (DRE) continues to increase. Our goal was to test the e... MM Schapira,J Vanruiswyk - 《Journa...